These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31120905)

  • 41. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
    Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
    Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle.
    Moltzau LR; Aronsen JM; Meier S; Skogestad J; Ørstavik Ø; Lothe GB; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
    J Pharmacol Exp Ther; 2014 Sep; 350(3):681-90. PubMed ID: 25022512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Local CNP/GC-B system in growth plate is responsible for physiological endochondral bone growth.
    Nakao K; Osawa K; Yasoda A; Yamanaka S; Fujii T; Kondo E; Koyama N; Kanamoto N; Miura M; Kuwahara K; Akiyama H; Bessho K; Nakao K
    Sci Rep; 2015 May; 5():10554. PubMed ID: 26014585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design and evaluation of novel natriuretic peptide derivatives with improved pharmacokinetic and pharmacodynamic properties.
    Morozumi N; Sato S; Yoshida S; Harada Y; Furuya M; Minamitake Y; Kangawa K
    Peptides; 2017 Nov; 97():16-21. PubMed ID: 28899838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
    Wegner M; Ganten D; Stasch JP
    Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ASB20123: A novel C-type natriuretic peptide derivative for treatment of growth failure and dwarfism.
    Morozumi N; Yotsumoto T; Yamaki A; Yoshikiyo K; Yoshida S; Nakamura R; Jindo T; Furuya M; Maeda H; Minamitake Y; Kangawa K
    PLoS One; 2019; 14(2):e0212680. PubMed ID: 30794654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells.
    Ozasa A; Komatsu Y; Yasoda A; Miura M; Sakuma Y; Nakatsuru Y; Arai H; Itoh N; Nakao K
    Bone; 2005 Jun; 36(6):1056-64. PubMed ID: 15869918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway.
    Matsushita T; Wilcox WR; Chan YY; Kawanami A; Bükülmez H; Balmes G; Krejci P; Mekikian PB; Otani K; Yamaura I; Warman ML; Givol D; Murakami S
    Hum Mol Genet; 2009 Jan; 18(2):227-40. PubMed ID: 18923003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advantages and Disadvantages of Different Treatment Methods in Achondroplasia: A Review.
    Wrobel W; Pach E; Ben-Skowronek I
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vosoritide: First Approval.
    Duggan S
    Drugs; 2021 Nov; 81(17):2057-2062. PubMed ID: 34694597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Achondroplasia Foramen Magnum Score: screening infants for stenosis.
    Cheung MS; Irving M; Cocca A; Santos R; Shaunak M; Dougherty H; Siddiqui A; Gringras P; Thompson D
    Arch Dis Child; 2021 Feb; 106(2):180-184. PubMed ID: 32883660
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating osteocrin stimulates bone growth by limiting C-type natriuretic peptide clearance.
    Kanai Y; Yasoda A; Mori KP; Watanabe-Takano H; Nagai-Okatani C; Yamashita Y; Hirota K; Ueda Y; Yamauchi I; Kondo E; Yamanaka S; Sakane Y; Nakao K; Fujii T; Yokoi H; Minamino N; Mukoyama M; Mochizuki N; Inagaki N
    J Clin Invest; 2017 Nov; 127(11):4136-4147. PubMed ID: 28990933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Skeletal analysis of the long bone abnormality (lbab/lbab) mouse, a novel chondrodysplastic C-type natriuretic peptide mutant.
    Kondo E; Yasoda A; Tsuji T; Fujii T; Miura M; Kanamoto N; Tamura N; Arai H; Kunieda T; Nakao K
    Calcif Tissue Int; 2012 Apr; 90(4):307-18. PubMed ID: 22271248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.
    Yasoda A; Komatsu Y; Chusho H; Miyazawa T; Ozasa A; Miura M; Kurihara T; Rogi T; Tanaka S; Suda M; Tamura N; Ogawa Y; Nakao K
    Nat Med; 2004 Jan; 10(1):80-6. PubMed ID: 14702637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased Bone Turnover and Possible Accelerated Fracture Healing in a Murine Model With an Increased Circulating C-Type Natriuretic Peptide.
    Kondo E; Yasoda A; Fujii T; Nakao K; Yamashita Y; Ueda-Sakane Y; Kanamoto N; Miura M; Arai H; Mukoyama M; Inagaki N; Nakao K
    Endocrinology; 2015 Jul; 156(7):2518-29. PubMed ID: 25860030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurosurgical Evaluation and Management of Children with Achondroplasia.
    Kashanian A; Stadler JA; Danielpour M
    Neurosurg Clin N Am; 2022 Jan; 33(1):17-23. PubMed ID: 34801138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction.
    Soeki T; Kishimoto I; Okumura H; Tokudome T; Horio T; Mori K; Kangawa K
    J Am Coll Cardiol; 2005 Feb; 45(4):608-16. PubMed ID: 15708711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dwarfism and early death in mice lacking C-type natriuretic peptide.
    Chusho H; Tamura N; Ogawa Y; Yasoda A; Suda M; Miyazawa T; Nakamura K; Nakao K; Kurihara T; Komatsu Y; Itoh H; Tanaka K; Saito Y; Katsuki M; Nakao K
    Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4016-21. PubMed ID: 11259675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How does occipitalization influence the dimensions of the cranium?
    Caspersen LM; Kjaer I; Sonnesen L
    Orthod Craniofac Res; 2010 Aug; 13(3):162-8. PubMed ID: 20618718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diverging vasorelaxing effects of C-type natriuretic peptide in renal resistance arteries and aortas of GC-A-deficient mice.
    Steinmetz M; Potthast R; Sabrane K; Kuhn M
    Regul Pept; 2004 Jun; 119(1-2):31-7. PubMed ID: 15093694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.